Global IBS-C Drug Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

Global IBS-C Drug Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

  • SKU :
    SAC9087661
  • Published Date :
    May 31, 2024
  • Number of Pages :
    350

Product Description

The IBS-C Drug market was valued at US$ xx in 2023. The market for IBS-C Drug is projected to grow from US$ xx million in 2024, and is projected to reach xx by 2031, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of IBS-C Drug industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading IBS-C Drug by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global IBS-C Drug market are discussed.

The market is segmented by types: 
    Linaclotide
    Lubiprostone
    Osmotic Laxatives
    Stimulant Laxatives
    Other

It can be also divided by applications:
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

And this report covers the historical situation, present status and the future prospects of the global IBS-C Drug market for 2021-2031. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.
    Catalent Pharmaceuticals Solutions
    Nestle
    Abbott Laboratories
    Synergy Pharmaceuticals
    Sucampo Pharmaceuticals
    Novartis Pharma
    Astellas Pharmaceuticals
    Ardelyx
    Synthetic Biologics
    Teva Pharmaceutical Industries
    Bama-Geve
    Ferring BV
    Ironwood Pharmaceuticals
    Salix Pharmaceuticals
    Norgine
    Prometheus Laboratories
    Actavis Nordic
    Albireo Pharma
    Yuhan Corp
    Astrazeneca
    The Menarini Group
    Ono Pharmaceutical

Report Includes:
- xx data tables and xx additional tables
- An overview of global IBS-C Drug market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2024 and projections of compound annual growth rates (CAGRs) through 2031
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the IBS-C Drug market
- Profiles of major players in the industry, including     Catalent Pharmaceuticals Solutions,     Nestle,     Abbott Laboratories,     Synergy Pharmaceuticals,     Sucampo Pharmaceuticals.....

Research objectives
    To study and analyze the global IBS-C Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2019 to 2021, and Forecast to 2031.
    To understand the structure of IBS-C Drug market by identifying its various subsegments.
    Focuses on the key global IBS-C Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
    To analyze the IBS-C Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To project the consumption of IBS-C Drug submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Content 

Table of Contents

Global IBS-C Drug Market Report 2024, Forecast to 2031

1 Scope of the Study
    1.1 IBS-C Drug Introduction
    1.2 Research Programs
    1.3 Analysis of Macroeconomic Indicators
    1.4 Years Considered
    1.5 Methodology
    1.6 Data Source
    1.7 Research Objectives

2 IBS-C Drug Industry Overview
    2.1 Global IBS-C Drug Market Size (Million USD) Comparison by Regions (2024-2031)
        2.1.1 IBS-C Drug Global Import Market Analysis
        2.1.2 IBS-C Drug Global Export Market Analysis
        2.1.3 IBS-C Drug Global Main Region Market Analysis
    2.2 Market Analysis by Type
        2.2.1 Linaclotide
        2.2.2 Lubiprostone
        2.2.3 Osmotic Laxatives
        2.2.4 Stimulant Laxatives
        2.2.5 Other
    2.3 Market Analysis by Application
        2.3.1 Hospital Pharmacies
        2.3.2 Retail Pharmacies
        2.3.3 Online Pharmacies
    2.4 Global IBS-C Drug Revenue, Sales and Market Share by Manufacturer
        2.4.1 Global IBS-C Drug Sales and Market Share by Manufacturer (2019-2023)
        2.4.2 Global IBS-C Drug Revenue and Market Share by Manufacturer (2019-2023)
        2.4.3 Global IBS-C Drug Industry Concentration Ratio (CR5 and HHI)
        2.4.4 Top 5 IBS-C Drug Manufacturer Market Share
        2.4.5 Top 10 IBS-C Drug Manufacturer Market Share
        2.4.6 Date of Key Manufacturers Enter into IBS-C Drug Market
        2.4.7 Key Manufacturers IBS-C Drug Product Offered
        2.4.8 Mergers & Acquisitions Planning
    2.5 IBS-C Drug Historical Development Overview
    2.6 Market Dynamics
        2.6.1 Market Opportunities
        2.6.2 Market Risk
        2.6.3 Market Driving Force
        2.6.4 Porter's Five Forces Analysis
    2.7 Coronavirus Disease 2019 (Covid-19): IBS-C Drug Industry Impact
        2.7.1 How the Covid-19 is Affecting the IBS-C Drug Industry
        2.7.2 IBS-C Drug Business Impact Assessment - Covid-19
        2.7.3 Market Trends and IBS-C Drug Potential Opportunities in the COVID-19 Landscape
        2.7.4 Measures / Proposal against Covid-19

3 Upstream and Downstream Market Analysis
    3.1 Upstream Analysis
        3.1.1 Macro Analysis of Upstream Markets
        3.1.2 Key Players in Upstream Markets
        3.1.3 Upstream Market Trend Analysis
        3.1.4 IBS-C Drug Manufacturing Cost Analysis
    3.2 Downstream Market Analysis
        3.2.1 Macro Analysis of Down Markets
        3.2.2 Key Players in Down Markets
        3.2.3 Downstream Market Trend Analysis
        3.2.4 Sales Channel, Distributors, Traders and Dealers

4 Global IBS-C Drug Market Size Categorized by Regions
    4.1 Global IBS-C Drug Revenue, Sales and Market Share by Regions
        4.1.1 Global IBS-C Drug Sales and Market Share by Regions (2019-2023)
        4.1.2 Global IBS-C Drug Revenue and Market Share by Regions (2019-2023)
    4.2 Europe IBS-C Drug Sales and Growth Rate (2019-2023)
    4.3 APAC IBS-C Drug Sales and Growth Rate (2019-2023)
    4.4 North America IBS-C Drug Sales and Growth Rate (2019-2023)
    4.5 South America IBS-C Drug Sales and Growth Rate (2019-2023)
    4.6 Middle East & Africa IBS-C Drug Sales and Growth Rate (2019-2023)

5 Europe IBS-C Drug Market Size Categorized by Countries
    5.1 Europe IBS-C Drug Sales, Revenue and Market Share by Countries
        5.1.1 Europe IBS-C Drug Sales by Countries (2019-2023)
        5.1.2 Europe IBS-C Drug Revenue by Countries (2019-2023)
        5.1.3 Germany IBS-C Drug Sales and Growth Rate (2019-2023)
        5.1.4 UK IBS-C Drug Sales and Growth Rate (2019-2023)
        5.1.5 France IBS-C Drug Sales and Growth Rate (2019-2023)
        5.1.6 Russia IBS-C Drug Sales and Growth Rate (2019-2023)
        5.1.7 Italy IBS-C Drug Sales and Growth Rate (2019-2023)
        5.1.8 Spain IBS-C Drug Sales and Growth Rate (2019-2023)
    5.2 Europe IBS-C Drug Revenue (Value) by Manufacturers (2019-2023)
    5.3 Europe IBS-C Drug Sales, Revenue and Market Share by Type (2019-2023)
        5.3.1 Europe IBS-C Drug Sales Market Share by Type (2019-2023)
        5.3.2 Europe IBS-C Drug Revenue and Revenue Share by Type (2019-2023)
    5.4 Europe IBS-C Drug Sales Market Share by Application (2019-2023)

6 Asia-Pacific IBS-C Drug Market Size Categorized by Countries
    6.1 Asia-Pacific IBS-C Drug Sales, Revenue and Market Share by Countries
        6.1.1 Asia-Pacific IBS-C Drug Sales by Countries (2019-2023)
        6.1.2 Asia-Pacific IBS-C Drug Revenue by Countries (2019-2023)
        6.1.3 China IBS-C Drug Sales and Growth Rate (2019-2023)
        6.1.4 Japan IBS-C Drug Sales and Growth Rate (2019-2023)
        6.1.5 Korea IBS-C Drug Sales and Growth Rate (2019-2023)
        6.1.6 India IBS-C Drug Sales and Growth Rate (2019-2023)
        6.1.7 Southeast Asia IBS-C Drug Sales and Growth Rate (2019-2023)
        6.1.8 Australia IBS-C Drug Sales and Growth Rate (2019-2023)
    6.2 Asia-Pacific IBS-C Drug Sales and Revenue (Value) by Manufacturers (2019-2023)
    6.3 Asia-Pacific IBS-C Drug Sales, Revenue and Market Share by Type (2019-2023)
        6.3.1 Asia-Pacific IBS-C Drug Sales Market Share by Type (2019-2023)
        6.3.2 Asia-Pacific IBS-C Drug Revenue and Revenue Share by Type (2019-2023)
    6.4 Asia-Pacific IBS-C Drug Sales and Market Share by Application (2019-2023)

7 North America IBS-C Drug Market Size Categorized by Countries
    7.1 North America IBS-C Drug Sales, Revenue and Market Share by Countries
        7.1.1 North America IBS-C Drug Sales by Countries (2019-2023)
        7.1.2 North America IBS-C Drug Revenue by Countries (2019-2023)
        7.1.3 United States IBS-C Drug Sales and Growth Rate (2019-2023)
        7.1.4 Canada IBS-C Drug Sales and Growth Rate (2019-2023)
        7.1.5 Mexico IBS-C Drug Sales and Growth Rate (2019-2023)
    7.2 North America IBS-C Drug Revenue (Value) by Manufacturers (2019-2023)
    7.3 North America IBS-C Drug Sales, Revenue and Market Share by Type (2019-2023)
        7.3.1 North America IBS-C Drug Sales Market Share by Type (2019-2023)
        7.3.2 North America IBS-C Drug Revenue and Revenue Share by Type (2019-2023)
    7.4 North America IBS-C Drug Sales Market Share by Application (2019-2023)

8 South America IBS-C Drug Market Size Categorized by Countries
    8.1 South America IBS-C Drug Sales, Revenue and Market Share by Countries
        8.1.1 South America IBS-C Drug Sales by Countries (2019-2023)
        8.1.2 South America IBS-C Drug Revenue by Countries (2019-2023)
        8.1.3 Brazil IBS-C Drug Sales and Growth Rate (2019-2023)
    8.2 South America IBS-C Drug Revenue (Value) by Manufacturers (2019-2023)
    8.3 South America IBS-C Drug Sales, Revenue and Market Share by Type (2019-2023)
        8.3.1 South America IBS-C Drug Sales Market Share by Type (2019-2023)
        8.3.2 South America IBS-C Drug Revenue and Revenue Share by Type (2019-2023)
    8.4 South America IBS-C Drug Sales Market Share by Application (2019-2023)

9 Middle East and Africa IBS-C Drug Market Size Categorized by Countries
    9.1 Middle East and Africa IBS-C Drug Sales, Revenue and Market Share by Countries
        9.1.1 Middle East and Africa IBS-C Drug Sales by Countries (2019-2023)
        9.1.2 Middle East and Africa IBS-C Drug Revenue by Countries (2019-2023)
        9.1.3 GCC Countries IBS-C Drug Sales and Growth Rate (2019-2023)
        9.1.4 Turkey IBS-C Drug Sales and Growth Rate (2019-2023)
        9.1.5 Egypt IBS-C Drug Sales and Growth Rate (2019-2023)
        9.1.6 South Africa IBS-C Drug Sales and Growth Rate (2019-2023)
    9.2 Middle East and Africa IBS-C Drug Revenue (Value) by Manufacturers (2019-2023)
    9.3 Middle East and Africa IBS-C Drug Sales, Revenue and Market Share by Type
        9.3.1 Middle East and Africa IBS-C Drug Sales Market Share by Type (2019-2023)
        9.3.2 Middle East and Africa IBS-C Drug Revenue and Revenue Share by Type (2019-2023)
    9.4 Middle East and Africa IBS-C Drug Sales Market Share by Application (2019-2023)

10 Global IBS-C Drug Market Segment by Type
    10.1 Global IBS-C Drug Revenue, Sales and Market Share by Type (2019-2023)
        10.1.1 Global IBS-C Drug Sales and Market Share by Type (2019-2023)
        10.1.2 Global IBS-C Drug Revenue and Market Share by Type (2019-2023)
    10.2 Linaclotide Sales Growth Rate and Price
        10.2.1 Global Linaclotide Sales Growth Rate (2019-2023)
        10.2.2 Global Linaclotide Price (2019-2023)
    10.3 Lubiprostone Sales Growth Rate and Price
        10.3.1 Global Lubiprostone Sales Growth Rate (2019-2023)
        10.3.2 Global Lubiprostone Price (2019-2023)
    10.4 Osmotic Laxatives Sales Growth Rate and Price
        10.4.1 Global Osmotic Laxatives Sales Growth Rate (2019-2023)
        10.4.2 Global Osmotic Laxatives Price (2019-2023)
    10.5 Stimulant Laxatives Sales Growth Rate and Price
        10.5.1 Global Stimulant Laxatives Sales Growth Rate (2019-2023)
        10.5.2 Global Stimulant Laxatives Price (2019-2023)
    10.6 Other Sales Growth Rate and Price
        10.6.1 Global Other Sales Growth Rate (2019-2023)
        10.6.2 Global Other Price (2019-2023)

11 Global IBS-C Drug Market Segment by Application
    11.1 Global IBS-C DrugSales Market Share by Application (2019-2023)
    11.2 Hospital Pharmacies Sales Growth Rate (2019-2023)
    11.3 Retail Pharmacies Sales Growth Rate (2019-2023)
    11.4 Online Pharmacies Sales Growth Rate (2019-2023)

12 Market Forecast for IBS-C Drug
    12.1 Global IBS-C Drug Revenue, Sales and Growth Rate (2024-2031)
    12.2 IBS-C Drug Market Forecast by Regions (2024-2031)
        12.2.1 Europe IBS-C Drug Market Forecast (2024-2031)
        12.2.2 APAC IBS-C Drug Market Forecast (2024-2031)
        12.2.3 North America IBS-C Drug Market Forecast (2024-2031)
        12.2.4 South America IBS-C Drug Market Forecast (2024-2031)
        12.2.5 Middle East & Africa IBS-C Drug Market Forecast (2024-2031)
    12.3 IBS-C Drug Market Forecast by Type (2024-2031)
        12.3.1 Global IBS-C Drug Sales Forecast by Type (2024-2031)
        12.3.2 Global IBS-C Drug Market Share Forecast by Type (2024-2031)
    12.4 IBS-C Drug Market Forecast by Application (2024-2031)
        12.4.1 Global IBS-C Drug Sales Forecast by Application (2024-2031)
        12.4.2 Global IBS-C Drug Market Share Forecast by Application (2024-2031)

13 Analysis of IBS-C Drug Industry Key Manufacturers
    13.1 Catalent Pharmaceuticals Solutions
        13.1.1 Company Details
        13.1.2 Product Information
        13.1.3 Catalent Pharmaceuticals Solutions IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.1.4 Main Business Overview
        13.1.5 Catalent Pharmaceuticals Solutions News
    13.2 Nestle
        13.2.1 Company Details
        13.2.2 Product Information
        13.2.3 Nestle IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.2.4 Main Business Overview
        13.2.5 Nestle News
    13.3 Abbott Laboratories
        13.3.1 Company Details
        13.3.2 Product Information
        13.3.3 Abbott Laboratories IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.3.4 Main Business Overview
        13.3.5 Abbott Laboratories News
    13.4 Synergy Pharmaceuticals
        13.4.1 Company Details
        13.4.2 Product Information
        13.4.3 Synergy Pharmaceuticals IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.4.4 Main Business Overview
        13.4.5 Synergy Pharmaceuticals News
    13.5 Sucampo Pharmaceuticals
        13.5.1 Company Details
        13.5.2 Product Information
        13.5.3 Sucampo Pharmaceuticals IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.5.4 Main Business Overview
        13.5.5 Sucampo Pharmaceuticals News
    13.6 Novartis Pharma
        13.6.1 Company Details
        13.6.2 Product Information
        13.6.3 Novartis Pharma IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.6.4 Main Business Overview
        13.6.5 Novartis Pharma News
    13.7 Astellas Pharmaceuticals
        13.7.1 Company Details
        13.7.2 Product Information
        13.7.3 Astellas Pharmaceuticals IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.7.4 Main Business Overview
        13.7.5 Astellas Pharmaceuticals News
    13.8 Ardelyx
        13.8.1 Company Details
        13.8.2 Product Information
        13.8.3 Ardelyx IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.8.4 Main Business Overview
        13.8.5 Ardelyx News
    13.9 Synthetic Biologics
        13.9.1 Company Details
        13.9.2 Product Information
        13.9.3 Synthetic Biologics IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.9.4 Main Business Overview
        13.9.5 Synthetic Biologics News
    13.10 Teva Pharmaceutical Industries
        13.10.1 Company Details
        13.10.2 Product Information
        13.10.3 Teva Pharmaceutical Industries IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.10.4 Main Business Overview
        13.10.5 Teva Pharmaceutical Industries News
    13.11 Bama-Geve
        13.11.1 Company Details
        13.11.2 Product Information
        13.11.3 Bama-Geve IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.11.4 Main Business Overview
        13.11.5 Bama-Geve News
    13.12 Ferring BV
        13.12.1 Company Details
        13.12.2 Product Information
        13.12.3 Ferring BV IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.12.4 Main Business Overview
        13.12.5 Ferring BV News
    13.13 Ironwood Pharmaceuticals
        13.13.1 Company Details
        13.13.2 Product Information
        13.13.3 Ironwood Pharmaceuticals IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.13.4 Main Business Overview
        13.13.5 Ironwood Pharmaceuticals News
    13.14 Salix Pharmaceuticals
        13.14.1 Company Details
        13.14.2 Product Information
        13.14.3 Salix Pharmaceuticals IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.14.4 Main Business Overview
        13.14.5 Salix Pharmaceuticals News
    13.15 Norgine
        13.15.1 Company Details
        13.15.2 Product Information
        13.15.3 Norgine IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.15.4 Main Business Overview
        13.15.5 Norgine News
    13.16 Prometheus Laboratories
        13.16.1 Company Details
        13.16.2 Product Information
        13.16.3 Prometheus Laboratories IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.16.4 Main Business Overview
        13.16.5 Prometheus Laboratories News
    13.17 Actavis Nordic
        13.17.1 Company Details
        13.17.2 Product Information
        13.17.3 Actavis Nordic IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.17.4 Main Business Overview
        13.17.5 Actavis Nordic News
    13.18 Albireo Pharma
        13.18.1 Company Details
        13.18.2 Product Information
        13.18.3 Albireo Pharma IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.18.4 Main Business Overview
        13.18.5 Albireo Pharma News
    13.19 Yuhan Corp
        13.19.1 Company Details
        13.19.2 Product Information
        13.19.3 Yuhan Corp IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.19.4 Main Business Overview
        13.19.5 Yuhan Corp News
    13.20 Astrazeneca
        13.20.1 Company Details
        13.20.2 Product Information
        13.20.3 Astrazeneca IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.20.4 Main Business Overview
        13.20.5 Astrazeneca News
    13.21 The Menarini Group
        13.21.1 Company Details
        13.21.2 Product Information
        13.21.3 The Menarini Group IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.21.4 Main Business Overview
        13.21.5 The Menarini Group News
    13.22 Ono Pharmaceutical
        13.22.1 Company Details
        13.22.2 Product Information
        13.22.3 Ono Pharmaceutical IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.22.4 Main Business Overview
        13.22.5 Ono Pharmaceutical News

14 Research Findings and Conclusion

15 Appendix

Search results for Pharmaceutical Industry

Select License Type

get a sample
Ask For Customization
Get a quote
Speak to Analyst
Buy Now

Chemical & Materials

Top Rated Products